Roche decides against selling diabetes device unit -sources

By Soyoung Kim and Jessica Toonkel NEW YORK (Reuters) – Swiss drugmaker Roche Holding AG has decided against trying to sell its blood glucose meter business, according to two people familiar with the matter. At least one other large drugmaker, Bayer AG , also scrapped plans to sell a diabetes device unit this year. In the past few months, Roche was looking to sell the business as the industry faced increased competition and lower reimbursement rates from U.S. government healthcare programs, people familiar with the matter told Reuters in May. …